Exploring the effects of DPP inhibition on the tumor immune landscape using RNAseq

We examined the effects of an oral small molecule DPP inhibitor (BXCL701) on PDAC tumor growth and tumor immune landscape using mT3-2D and Pan02 subcutaneous syngeneic murine models in C57BL/6 mice Overall design: Exploration of the effects of DPP inhibition on the tumor immune landscape at different time points using RNAseq in C57BL/6 mice